Pathology EMQ template

Name:        Kumail Versi

Candidate number:     00471715

Theme:      Leukaemia

 

OPTION LIST

 

A	ALL	I	Myelodysplasia
B	AML	J	Non-Hodgkins Lymphoma
C	Class I mutation	K	Tretinoin (ATRA)
D	Class II mutation	L
E	CLL	M
F	CML	N
G	FLT3 inhibitor	O
H	Multiple Myeloma	P

 

 

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

 

1. Used to prevent mutation which confers proliferative advantage.

 

 

2. Impairs haematopoietic differentiation and subsequent apoptosis.

 

 

3. The Philadelphia chromosome is most commonly associated with this form of cancer.

 

 

4. Imatinib is the 1^st line therapy for this form of cancer.

 

 

5. The translocation t(8;21) signifies this form of cancer.

 

 

 

ANSWERS

1. G

2. D

3. F

4. F

5. B